Skip to main content
. Author manuscript; available in PMC: 2023 Aug 17.
Published in final edited form as: ACS Appl Mater Interfaces. 2022 Aug 7;14(32):36451–36461. doi: 10.1021/acsami.2c09420

Figure 7.

Figure 7.

(A−D) Yap1 and osteogenic gene expressions on the tubular and flat matrices after the treatment of ROCK inhibitor for 7 days. (E−H) Twist1 and osteogenic gene expressions on the tubular and flat matrices after the treatment of Twist1 esiRNA for 7 days. P < 0.05 was considered statistically significant. (∗) Compared to the control group.